Based on the advantages of the microarray chip scanner method that has been successfully developed for the first time in the world, it was certified as Class 2 medical device by the Ministry of Food and Drug Safety. The lateral flow rapid diagnostic chip reader that applies nano gold and fluorescence has recently been successfully developed. Also, related various diagnostic kits has been developing.
NanoBioLife develops and manufactures in vitro diagnostic tests, which were confirmed and certified by CE, ISO13485, FSC etc., based on immunochemical diagnostic technology for early diagnosis of diseases.
As a product with high economical efficiency and high sensitivity for quantitative analysis, it will be effectively utilized for early diagnosis of diseases.

In addition, NanoBioLife developed for the first time in Korea as a smart recumbent exercise device for cardiovascular patients along with the Wellness Center of the Cardiovascular Hospital of Yonsei Medical Center as an industry fostering project of the Ministry of Commerce, Industry and Energy.The smart recumbent exercise device has been approved as a grade 2 medical device item, and it will be developed as a balancing and deficit muscle strengthening trainer system that can be extended to stroke patients in the future.

Our health care equipment and precision detection and analysis technology provide a foundation for personalized health care, early disease diagnosis, preventive medicine, and new drug development for a 100-year-old with a healthy life, which can have a ripple effect on national health promotion and industrial development. This is a useful technique.

In the future, we will become a company that increases the value for customers by supplying excellent products with specialized ideas and technologies.